Scorpion Venom Peptides With Antiviral Activity Against HIV, Hepatitis, and SARS-CoV-2
Several peptides isolated from scorpion venom have demonstrated antiviral activity against major virus families including HIV, hepatitis, and coronaviruses, representing potential new therapeutic candidates.
Quick Facts
What This Study Found
Multiple scorpion venom peptides have demonstrated antiviral activity against several viral families, with potential biomedical applications against HIV, hepatitis, and coronaviruses.
Key Numbers
Active against HIV-1, HCV, HSV-1, measles virus, coronaviruses; mechanisms include membrane disruption, entry blocking, replication interference
How They Did This
Narrative review of published literature on scorpion-derived antiviral peptides, their mechanisms of action, and potential biomedical applications.
Why This Research Matters
With viral pandemics remaining a global threat, scorpion venom peptides represent an underexplored source of antiviral compounds that could lead to new treatments, especially as antibiotic resistance grows.
The Bigger Picture
Venom-derived peptides are increasingly recognized as a rich source of pharmaceutical leads. Scorpion antiviral peptides join a growing list of venom-derived molecules being explored for drug development, including cone snail and spider venom peptides.
What This Study Doesn't Tell Us
Review article with no new data. Most antiviral testing has been in vitro only. Scorpion peptide stability, toxicity, and delivery remain significant challenges for clinical development.
Questions This Raises
- ?Which specific scorpion peptides have the strongest antiviral potency and selectivity?
- ?Can scorpion antiviral peptides be synthesized or modified for improved stability and reduced toxicity?
- ?Could scorpion venom peptides serve as templates for designing new broad-spectrum antivirals?
Trust & Context
- Key Stat:
- Multiple virus families Scorpion venom peptides have shown antiviral activity against HIV, hepatitis C, and coronaviruses across different studies
- Evidence Grade:
- Not applicable (narrative review). Based primarily on in vitro antiviral testing data.
- Study Age:
- Published in 2021. Antiviral peptide research has continued to expand, particularly for coronaviruses.
- Original Title:
- Scorpion-Derived Antiviral Peptides with a Special Focus on Medically Important Viruses: An Update.
- Published In:
- BioMed research international, 2021, 9998420 (2021)
- Authors:
- El Hidan, Moulay Abdelmonaim, Laaradia, Mehdi Ait, El Hiba, Omar, Draoui, Ahmed, Aimrane, Abdelmohcine, Kahime, Kholoud
- Database ID:
- RPEP-05361
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Can scorpion venom really fight viruses?
Yes — certain peptides found in scorpion venom have been shown to inhibit viruses in laboratory tests. These peptides likely evolved as part of the scorpion's immune defense system and can disrupt viral entry or replication.
Are scorpion venom antivirals available as medicine?
Not yet. These peptides are in very early research stages. Significant work on safety, stability, delivery, and clinical testing would be needed before they could become treatments.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05361APA
El Hidan, Moulay Abdelmonaim; Laaradia, Mehdi Ait; El Hiba, Omar; Draoui, Ahmed; Aimrane, Abdelmohcine; Kahime, Kholoud. (2021). Scorpion-Derived Antiviral Peptides with a Special Focus on Medically Important Viruses: An Update.. BioMed research international, 2021, 9998420. https://doi.org/10.1155/2021/9998420
MLA
El Hidan, Moulay Abdelmonaim, et al. "Scorpion-Derived Antiviral Peptides with a Special Focus on Medically Important Viruses: An Update.." BioMed research international, 2021. https://doi.org/10.1155/2021/9998420
RethinkPeptides
RethinkPeptides Research Database. "Scorpion-Derived Antiviral Peptides with a Special Focus on ..." RPEP-05361. Retrieved from https://rethinkpeptides.com/research/el-2021-scorpionderived-antiviral-peptides-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.